Basit öğe kaydını göster

dc.contributor.authorAkyuz, Filiz
dc.contributor.authorKaymakoglu, Sabahattin
dc.contributor.authorOrmeci, Asli Ciftcibasi
dc.contributor.authorDemir, Kadir
dc.contributor.authorBesisik, Fatih
dc.contributor.authorKayar, Yusuf
dc.contributor.authorDertli, Ramazan
dc.contributor.authorKonur, Sevki
dc.contributor.authorAgin, Mehmet
dc.contributor.authorBaran, Bulent
dc.date.accessioned2021-03-02T17:30:12Z
dc.date.available2021-03-02T17:30:12Z
dc.identifier.citationKayar Y., Dertli R., Konur S., Agin M., Baran B., Ormeci A. C. , Akyuz F., Demir K., Besisik F., Kaymakoglu S., "The development of extraintestinal manifestation and related risk factors in Crohn's patients", IRISH JOURNAL OF MEDICAL SCIENCE, 2020
dc.identifier.issn0021-1265
dc.identifier.othervv_1032021
dc.identifier.otherav_9deacdf3-1701-4142-a0b6-2aa5608b693d
dc.identifier.urihttp://hdl.handle.net/20.500.12627/3872
dc.identifier.urihttps://doi.org/10.1007/s11845-020-02326-z
dc.description.abstractBackground Crohn's disease (CD) primarily involves gastrointestinal tract; however, it can present with extraintestinal manifestations (EIMs), which leads to significant morbidity. Frequency of EIMs and associated risk factors vary due to genetic and environmental differences in studies. Aim To examine the frequency and risk factors associated with EIMs in CD. Method Patients with CD under follow-up from March 1986 to October 2011 were included in this study. Demographics, type of EIMs, autoimmune diseases, and clinical features of CD were recorded. Frequency of EIMs and associated risk factors were analyzed. Results Three hundred thirty-six patients with CD were included in the study (mean follow-up duration 7.54 years). 55.4% (n: 186) were male and the mean age at diagnosis of CD was 30.6 years (range, 10.3-68.2 years). At least one EIM was detected in 47.3% and multiple EIMs in 22.9% of the cohort. Oral, joint, and skin involvements (32.4%, 24.7%, 9.2%, respectively) were the most common EIMs. Female gender (OR: 2.19, 95% CI: 1.34-3.58,p = 0.001), corticosteroid usage (OR: 2.32, 95% CI: 1.28-4.22,p = 0.007), and positive family history (OR: 5.61, 95% CI: 1.95-3.58,p = 0.001) were independent risk factors for EIM development. Colonic involvement (OR: 3.93, 95% CI: 1.59-9.68,p = 0.003), no surgical operation (OR: 2.31, 95% CI: 1.14-4.68,p = 0.020), and corticosteroid usage (OR: 2.85, 95% CI: 1.07-7.61,p = 0.037) were independent risk factors for multiple EIM development. Conclusion Although the immunological and clinical associations between EIMs and CD cannot be fully elucidated, identifying specific relationships of immune-mediated diseases will help to better understand CD pathogenesis.
dc.language.isoeng
dc.subjectTemel Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectTIP, GENEL & İÇECEK
dc.titleThe development of extraintestinal manifestation and related risk factors in Crohn's patients
dc.typeMakale
dc.relation.journalIRISH JOURNAL OF MEDICAL SCIENCE
dc.contributor.departmentUniversity of Health Sciences Turkey , ,
dc.contributor.firstauthorID2285566


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster